Biotricity Inc. (BTCY): Gross Profit

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2020-03-31, 2021-03-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$12.95M

Year ended 2026-03-31

$13.36M

Trailing 12 months to 2026-06-30

+33.5%

3-year compound annual growth

+59.0%

5-year compound annual growth

2019-03-31 Gross Profit (USD) 2026-03-31

Period ended	Gross Profit	Change YoY	Source filing
2026-03-31	$12.95M	+22.6%	2026-07-14, From 2025-04-01
2025-03-31	$10.56M	+26.4%	2026-07-14, From 2024-04-01
2024-03-31	$8.36M	+53.6%	2025-07-18, From 2023-04-01
2023-03-31	$5.44M	+19.1%	2024-06-27, From 2022-04-01
2022-03-31	$4.57M	+259.1%	2023-06-29, From 2021-04-01
2021-03-31	$1.27M	n/c	2022-07-14, From 2020-04-01
2020-03-31	$485.8K	n/c	2021-06-22, From 2019-04-01
2019-03-31	$59.9K	n/a	2020-07-15, From 2018-04-01

Gross Profit at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

Company	Year ended	Gross Profit	Change YoY
Biotricity Inc. (BTCY)	2026-03-31	$12.95M	+22.6%
Profound Medical Corp. (PROF)	2025-12-31	$11.39M	+61.9%
Allurion Technologies, Inc. (ALUR)	2025-12-31	$9.57M	-55.5%
Vivos Therapeutics, Inc. (VVOS)	2025-12-31	$10.54M	+16.9%
Nephros Inc (NEPH)	2025-12-31	$11.62M	+33.3%
Sonoma Pharmaceuticals, Inc. (SNOA)	2026-03-31	$7.42M	+35.7%
Spectral AI, Inc. (MDAI)	2025-12-31	$8.93M	-32.8%
DarioHealth Corp. (DRIO)	2025-12-31	$12.66M	-4.5%
Nexgel, Inc. (NXGL)	2025-12-31	$4.51M	+64.1%

Compare BTCY, PROF, ALUR, VVOS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗